One in three patients who defeat Code 19 develops long-term symptoms of the disease.
This was revealed in a medical study conducted in the United States.
The University of California study examined long code in cod patients in Long Beach.
The term long code is used for patients who experience various symptoms several weeks or months after the onset of the disease.
The study found that even 2 months after the diagnosis, one in three cod patients still have at least one symptom.
The study also found that people 40 years of age or older, women, and people already with a disease have a higher rate of long codes.
The study included 366 adults who were diagnosed with COD in 2020.
During the study, 35% of people reported at least one symptom two months after the initial positive test.
17% of Longwood patients reported fatigue, 13% reported difficulty breathing and loss of sense of smell or taste, and 11% reported joint or joint pain.
The researchers say the findings are important for experts who will help them develop strategies to prevent and treat the problem in people at risk of long-term illness.
The researchers said that the number of people involved in the study was limited and more research was needed to determine how long these symptoms lasted.
Experts say that vaccination not only reduces the risk of contracting the code, but also reduces the risk of developing long code after a possible breakthrough infection.
The findings were published in the CDC's Morbidity and Mortality Weekly Reports.
Earlier, in early September 2021, a study by King's College London in the UK found that people who took two doses of the vaccine were more likely to develop a breakthrough infection (a term used for disease after vaccination). They have a 49% lower chance of long code.
For this study by King's College London, experts analyzed data from the UK Zoe's Code Sympathies Stud App, which was collected from 8 December 2020 to 4 July 2021.
This was the data of millions of people out of which 1.24 million people used one dose of vaccine while 971,504 people used two doses.
The researchers compared various factors, including age, physical or mental decline, and others with post-vaccination disease.
The study found that even if someone unfortunately gets cod after 2 doses of the vaccine, the risk of long-term symptoms is 49% lower than in patients who have not been vaccinated.
